Common side effects for both include: Mild injection-site reactions (small bump or redness, resolves within hours) Transient water retention in the first 1-2 weeks Vivid dreams in the first week (often a positive sign of deepening REM cycles) Occasional brief flushing sensation immediately after injection more common with CJC-1295/Ipamorelin Mild tingling or fatigue in the first few doses, typically resolves quickly Less common but serious considerations include effects on glucose tolerance (worth monitoring if you're insulin-resistant or diabetic), the potential for joint discomfort if dose is too high, and any contraindications related to active cancer, severe pituitary issues, or specific medications
The key insight is not only that glutathione participates in multiple physiologic pathways, but that its value depends on context
Though currently only FDA-approved for type 2 diabetes and obesity, people who have type 1 diabetes may want to take GLP-1 agonists for benefits besides just shedding unwanted pounds
This hormone activates receptors that control skin color, metabolism, and cellular signaling
ConjuChem has even added DAC to Insulin
CJC-1295 has been studied for its role in influencing markers associated with aging, sleep patterns, body composition, and recovery processes in controlled research settings [1]
